Markus Renschler - Feb 29, 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
President and CEO, Director
Signature
/s/ David Gaiero, as attorney-in-fact for Markus Renschler, M.D.
Stock symbol
CYT
Transactions as of
Feb 29, 2024
Transactions value $
$35,004
Form type
4
Date filed
3/5/2024, 06:10 PM
Previous filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Options Exercise $21.3K +12.6K +1.16% $1.69 1.09M Feb 29, 2024 Direct
transaction CYT Common Stock Options Exercise $3.04K +2.54K +0.23% $1.20 1.1M Feb 29, 2024 Direct
transaction CYT Common Stock Options Exercise $10.7K +6.3K +0.57% $1.69 1.1M Mar 4, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -12.6K -5.26% $0.00 227K Feb 29, 2024 Common Stock 12.6K $1.69 Direct F1
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -2.54K -100% $0.00* 0 Feb 29, 2024 Common Stock 2.54K $1.20 Direct
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -6.3K -2.78% $0.00 221K Mar 4, 2024 Common Stock 6.3K $1.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the underlying shares on each monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.